Paper9748012
Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group.
Apfel SC and 5 others. Neurology, 1998. Cited by 250 papers, by iCite.
Cite this record
ConductScience Library. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. Papers, record 9748012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9748012
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetic Neuropathies | Major topic |
| Nerve Growth Factors | Major topic |
| Adolescent | |
| Adult | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Neural Conduction | |
| Recombinant Proteins | |
| Sensation | |
| Treatment Outcome |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01744704 | Study to Evaluate Safety, Tolerability and Pharmacokinetics of rhNGF Eye Drops in Healthy Volunteers | Background | ClinicalTrials.gov | |
| NCT03968042 | Efficacy and Safety of Nerve Growth Factor or Edaravone on Alcohol-induced Brain Injury | Background | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 9748004 | Recombinant human nerve growth factor and diabetic polyneuropathy. | https://conductscience.org/library/papers/9748004 |
Source PubMed
Cited by70
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 250 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42564001 | Mechanisms, translational opportunities for diabetic polyneuropathy. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42564001 | PubMed |
| 42313885 | Understanding Motor Adaptation in the Transition to Sustained Pain: Protocol for a Longitudinal Experimental Study. | JMIR Res Protoc | 2026 | https://conductscience.org/library/papers/42313885 | PubMed |
| 41316697 | Electrophysiological diagnosis using the coefficient of variation of R-R intervals and a point-of-care nerve conduction device is highly correlated to the diagnosis of diabetic polyneuropathy using conventional electromyographs. | J Diabetes Investig | 2026 | https://conductscience.org/library/papers/41316697 | PubMed |
| 40153582 | 1953-2023. Seventy Years of the Nerve Growth Factor: A Potential Novel Treatment in Neurological Diseases? | Aging Dis | 2024 | https://conductscience.org/library/papers/40153582 | PubMed |
| 39996814 | NGF in Neuropathic Pain: Understanding Its Role and Therapeutic Opportunities. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/39996814 | PubMed |
| 39315114 | Sustained nerve growth factor-induced C-nociceptor sensitization to electrical sinusoidal stimulation in humans. | Pain Rep | 2024 | https://conductscience.org/library/papers/39315114 | PubMed |
| 38429927 | Gene therapy approaches for obesity-induced adipose neuropathy: Device-targeted AAV-mediated neurotrophic factor delivery to adipocytes in subcutaneous adipose. | Mol Ther | 2024 | https://conductscience.org/library/papers/38429927 | PubMed |
| 37520975 | Clinical evaluation of the perception of post-trauma paresthesia in the mandible, using a biomimetic material: A preliminary study in humans. | Heliyon | 2023 | https://conductscience.org/library/papers/37520975 | PubMed |
| 37190099 | Improving Schwann Cell Differentiation from Human Adipose Stem Cells with Metabolic Glycoengineering. | Cells | 2023 | https://conductscience.org/library/papers/37190099 | PubMed |
| 36412335 | The efficacy of new neuronal growth factor in the healing of the sciatic nerves in rabbits. | Ann Afr Med | 2022 | https://conductscience.org/library/papers/36412335 | PubMed |
| 35127954 | An Insight into Potential Pharmacotherapeutic Agents for Painful Diabetic Neuropathy. | J Diabetes Res | 2022 | https://conductscience.org/library/papers/35127954 | PubMed |
| 34935118 | Neurobiological Opportunities in Diabetic Polyneuropathy. | Neurotherapeutics | 2021 | https://conductscience.org/library/papers/34935118 | PubMed |
| 34780798 | Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes. | Am J Ophthalmol | 2022 | https://conductscience.org/library/papers/34780798 | PubMed |
| 34335170 | Nerve Growth Factor Biodelivery: A Limiting Step in Moving Toward Extensive Clinical Application? | Front Neurosci | 2021 | https://conductscience.org/library/papers/34335170 | PubMed |
| 33713848 | The TrkA agonist gambogic amide augments skeletal adaptation to mechanical loading. | Bone | 2021 | https://conductscience.org/library/papers/33713848 | PubMed |
| 33641595 | Nerve Growth Factor as an Ocular Therapy: Applications, Challenges, and Future Directions. | Semin Ophthalmol | 2021 | https://conductscience.org/library/papers/33641595 | PubMed |
| 32693191 | A missense point mutation in nerve growth factor (NGFR100W) results in selective peripheral sensory neuropathy. | Prog Neurobiol | 2020 | https://conductscience.org/library/papers/32693191 | PubMed |
| 32412144 | Evolving concepts on the role of dyslipidemia, bioenergetics, and inflammation in the pathogenesis and treatment of diabetic peripheral neuropathy. | J Peripher Nerv Syst | 2020 | https://conductscience.org/library/papers/32412144 | PubMed |
| 30899338 | Is the Diabetic Bladder a Neurogenic Bladder? Evidence from the Literature. | Curr Bladder Dysfunct Rep | 2014 | https://conductscience.org/library/papers/30899338 | PubMed |
| 30675270 | Targeting the BDNF/TrkB pathway for the treatment of tumors. | Oncol Lett | 2019 | https://conductscience.org/library/papers/30675270 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NGF | 4803 | PubTator's text mining | https://conductscience.org/library/genes/4803 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9748012
GET https://conductscience.org/api/papers/v1/9748012/cited_by?page=2